Goebelsmann U, Hall T D, Paul W L, Stanczyk F Z
J Clin Endocrinol Metab. 1975 Dec;41(06):1136-43. doi: 10.1210/jcem-41-6-1136.
In order to document testicular 17beta-reduction deficiency (17RD) and to search for additional metabolic aberrations possibly associated with this disorder, the metabolism of 14C-labeled pregnenolone (delta5P), 17-HYDROXYPROGESTERONE (17OHP), dehydroepiandrosterone (DHEA), androstenedione (A), testosterone (T) and estrone (E1) was studied in testicular minces from a 46-year-old male pseudohermaphrodite (MPH) with highly elevated testicular A and minimal T secretion but normal extragonadal conversion of A to T. Testicular minces from a 20-year-old MPH with apparently normal testicular T biosynthesis served as a control. The results of this investigation show that the 17RD testes metabolized delta5P along delta5- and delta4- pathways but, in contrast to the control, converted more 17OHP, metabolizing it predominantly to A rather than T, failed to reduce DHEA to androst-5-ene-3beta,17beta-diol, metabolized DHEA very efficiently to A and produced little T, and converted only minimal quantities of A and E1 to their 17beta-reduced counterparts. 17beta-Reduction increased slightly but was far from being restored to control levels upon addition of NADH plus NADPH. However, oxidation of T to A by 17RD testicular minces, with and without additional NAD plus NADP, was comparable to that by the control. These results document 17RD for A, DHEA and E1 and suggest that the lack of elevated 17OHP and DHEA secretion by the 17RD testes was due to increased 17, 20-lyase and perhaps elevated 3beta-hydroxysteroid dehydrogenase and/or isomerase activity. The observation that 17beta-reduction was only slightly increased upon addition of NADH plus NADPH, but that oxidation of T to A was normal, is consistent with the assumption that more than one 17beta-hydroxysteroid dehydrogenase may be involved in testicular 17beta-reduction and/or 17-oxidation, and that the 17RD testes studied either lacked the enzyme which acts predominantly as 17beta-reductase or that the affinity of this 17beta-reductase for reduced cofactor(s) and/or substrates was abnormal.
为了记录睾丸17β-还原缺陷(17RD)并寻找可能与该疾病相关的其他代谢异常,我们研究了一名46岁男性假两性畸形(MPH)患者睾丸匀浆中14C标记的孕烯醇酮(δ5P)、17-羟孕酮(17OHP)、脱氢表雄酮(DHEA)、雄烯二酮(A)、睾酮(T)和雌酮(E1)的代谢情况。该患者睾丸A水平显著升高,T分泌极少,但性腺外A向T的转化正常。一名2�岁MPH患者的睾丸匀浆作为对照,其睾丸T生物合成明显正常。本研究结果表明,17RD睾丸沿δ5-和δ4-途径代谢δ5P,但与对照相比,17OHP转化更多,主要将其代谢为A而非T,未能将DHEA还原为雄甾-5-烯-3β,17β-二醇,能非常有效地将DHEA代谢为A且产生的T很少,仅将少量的A和E1转化为其17β-还原产物。添加NADH加NADPH后,17β-还原略有增加,但远未恢复到对照水平。然而,无论有无额外的NAD加NADP,17RD睾丸匀浆将T氧化为A的情况与对照相当。这些结果证明了A、DHEA和E1存在17RD,并表明17RD睾丸缺乏升高的17OHP和DHEA分泌是由于17,20-裂解酶增加,可能还有3β-羟类固醇脱氢酶和/或异构酶活性升高。添加NADH加NADPH后17β-还原仅略有增加,但T氧化为A正常,这一观察结果与以下假设一致:可能有不止一种17β-羟类固醇脱氢酶参与睾丸17β-还原和/或17-氧化,且所研究的17RD睾丸要么缺乏主要作为17β-还原酶起作用的酶,要么该17β-还原酶对还原型辅因子和/或底物的亲和力异常。